Li Peng, PhD

Palleon Pharmaceuticals
Waltham, Massachusetts, United States

TBD

Presentation(s):

• 0908: E-602 (Efgitasialase alfa) Enhances Memory B Cell Depletion and Reduces Profibrotic Macrophages via Desialylation in Autoimmune Disease

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose